findmyKOL

Marie Caldwell, MD

Basic profile

The Ohio State University Comprehensive Cancer Center

ORCIDNPI
RegionScarborough, ME · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Marie Caldwell is an Endocrinology/Metabolic physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 13 publications with 261 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex, matched via ORCID.

261citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

175 Us Route 1
Scarborough, ME 040749048

Telephone

207-396-7700

Registry record last updated 26 Jul 2019.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    48.4%
    Insulin Analog18.1%
    Novolog17%Lantus Solostar17%Novolog Flexpen17%Basaglar Kwikpen U-10016%Fiasp Flextouch10%Humalog Kwikpen U-1008%Insulin Lispro8%Tresiba Flextouch U-1007%
    Part D<11 patients
    GLP-1 receptor agonist11.5%
    Trulicity45%Ozempic29%Mounjaro26%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    43.7%
    l-Thyroxine32.2%
    Levothyroxine Sodium87%Synthroid13%
    Part D66 patients
    Thyroid Hormone Synthesis Inhibitor7.7%
    Methimazole100%
    Part D20 patients

    + 3 more classes in this area

  • Genitourinary & hormones

    2.8%
    Androgen2.8%
    Testosterone Cypionate100%
    Part D<11 patients
Where care is delivered (Part B)8.4% facility · 91.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”